TransMedics (TMDX) Capital Expenditures Growth (1y) (2019 - 2026)
TransMedics (TMDX) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | -47.73% |
| 10 | TransMedics | 2.51 Bn | 2.05 Bn | 101.16 Mn | 35.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.58% |
| Dec 31, 2025 | 113.38% |
| Sep 30, 2025 | -62.34% |
| Jun 30, 2025 | 38.77% |
| Mar 31, 2025 | -38.79% |
| Dec 31, 2024 | -176.41% |
| Sep 30, 2024 | 683,123.53% |
| Jun 30, 2024 | -5,057.48% |
| Mar 31, 2024 | 4,665.05% |
| Dec 31, 2023 | 5,391.79% |
| Sep 30, 2023 | -100.22% |
| Jun 30, 2023 | -320.62% |
| Mar 31, 2023 | -1.28% |
| Dec 31, 2022 | -13.00% |
| Sep 30, 2022 | 11,227.54% |
| Jun 30, 2022 | 45.86% |
| Mar 31, 2022 | 13,314.29% |
| Dec 31, 2021 | 640.56% |
| Sep 30, 2021 | 428.57% |
| Jun 30, 2021 | 509.23% |